A multidisciplinary skull base board for tumour and non-tumour diseasesUrbančič, Jure (Avtor) Battelino, Saba (Avtor) Bošnjak, Roman (Avtor) Felbabić, Tomislav (Avtor) Steiner, Nejc (Avtor) Vouk, Matej (Avtor) Vrabec, Matej (Avtor) Vozel, Domen (Avtor) skull base neoplasmscarcinomaremote consultationparanasal sinusesear neoplasmsinvasive fungal infectionscentral nervous system neoplasmscranial nerve disordersneuroendoscopyThe skull base is the area where various cancerous and non-cancerous diseases occur and represents the intersection of several medical fields. The key is an integrated treatment by specialists of multiple disciplines. We prospectively analysed patients with a skull base disease between August 2022 and 2023 and presented to the Multidisciplinary Skull Base Board (MDT-SB), which takes place once a month hybridly (in-person and remotely). Thirty-nine patients (median age of 58.2 years) were included, of which twelve (30.8%) had a benign tumour, twelve (30.8%) had a malignant tumour, five had an infection (12.8%), and ten (25.6%) had other diseases. For each patient, at least two otorhinolaryngologists, a neurosurgeon, and a neuroradiologist, as well as an infectious disease specialist, a paediatrician, an oculoplastic surgeon, a maxillofacial surgeon, and a pathologist were involved in 10%, 8%, 8%, 3%, and 3% of cases, respectively. In fifteen patients (38%), the MDT-SB suggested surgical treatment; in fourteen (36%), radiological follow-ups; in five (13%), non-surgical treatments; in two, conservative treatments (5%); in two (5%), surgical and conservative treatments; and in one (3%), a biopsy. Non-cancerous and cancerous diseases of the skull base in adults and children should be presented to the MDT-SB, which consists of at least an otolaryngologist, a neurosurgeon, and a neuroradiologist.20242026-06-12 10:05:41Neznano30033sl